# Green Dot Corp: financial statements, quarterly

GDOT · NYSE · CIK 1386278 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gdot.md) · [Financials](/companies/gdot/financials.md) · [Filings](/companies/gdot/filings.md) · [Insiders](/companies/gdot/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gdot/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [345](/filings/0001386278-24-000080.md) | [358 d](/filings/0001386278-26-000015.md) | [439](/filings/0001386278-25-000034.md) | [392](/filings/0001386278-25-000064.md) | [394](/filings/0001386278-25-000076.md) | [436 d](/filings/0001386278-26-000015.md) | [537](/filings/0001386278-26-000035.md) | [483](/filings/0001386278-26-000045.md) | [472](/filings/0001386278-25-000076.md) | [499 d](/filings/0001386278-26-000015.md) | [629](/filings/0001386278-26-000035.md) | [574](/filings/0001386278-26-000045.md) |
| Operating income | $m | [(6.8)](/filings/0001386278-24-000080.md) | [(26.3) d](/filings/0001386278-26-000015.md) | [10.6](/filings/0001386278-25-000034.md) | [(23.7)](/filings/0001386278-25-000064.md) | [(2.9)](/filings/0001386278-25-000076.md) | [14.4 d](/filings/0001386278-26-000015.md) | [60.7](/filings/0001386278-26-000035.md) | [13.4](/filings/0001386278-26-000045.md) | [(32.8)](/filings/0001386278-25-000076.md) | [(27.7) d](/filings/0001386278-26-000015.md) | [69.0](/filings/0001386278-26-000035.md) | [(0.8)](/filings/0001386278-26-000045.md) |
| Income tax | $m | [(1.6)](/filings/0001386278-24-000080.md) | [(2.5) d](/filings/0001386278-26-000015.md) | [2.5](/filings/0001386278-25-000034.md) | [(0.8)](/filings/0001386278-25-000064.md) | [(0.4)](/filings/0001386278-25-000076.md) | [2.8 d](/filings/0001386278-26-000015.md) | [7.9](/filings/0001386278-26-000035.md) | [(15.9)](/filings/0001386278-26-000045.md) | [(4.9)](/filings/0001386278-25-000076.md) | [14.5 d](/filings/0001386278-26-000015.md) | [13.9](/filings/0001386278-26-000035.md) | [(0.3)](/filings/0001386278-26-000045.md) |
| Net income | $m | [(6.3)](/filings/0001386278-24-000080.md) | [(23.6) d](/filings/0001386278-26-000015.md) | [4.8](/filings/0001386278-25-000034.md) | [(28.7)](/filings/0001386278-25-000064.md) | [(7.8)](/filings/0001386278-25-000076.md) | [5.1 d](/filings/0001386278-26-000015.md) | [25.8](/filings/0001386278-26-000035.md) | [(47.0)](/filings/0001386278-26-000045.md) | [(30.8)](/filings/0001386278-25-000076.md) | [(46.8) d](/filings/0001386278-26-000015.md) | [53.8](/filings/0001386278-26-000035.md) | [(2.1)](/filings/0001386278-26-000045.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [711](/filings/0001386278-24-000080.md) | [682](/filings/0001386278-26-000015.md) | [1,119](/filings/0001386278-25-000034.md) | [1,317](/filings/0001386278-25-000064.md) | [1,454](/filings/0001386278-25-000076.md) | [1,592](/filings/0001386278-26-000015.md) | [1,773](/filings/0001386278-26-000035.md) | [2,313](/filings/0001386278-26-000045.md) | [1,637](/filings/0001386278-25-000076.md) | [1,422](/filings/0001386278-26-000045.md) | [1,646](/filings/0001386278-26-000035.md) | [1,143](/filings/0001386278-26-000045.md) |
| Current assets | $m | [1,540](/filings/0001386278-23-000062.md) | [1,638](/filings/0001386278-25-000009.md) | [2,224](/filings/0001386278-24-000031.md) | [2,425](/filings/0001386278-24-000051.md) | [2,219](/filings/0001386278-24-000080.md) | [2,428](/filings/0001386278-26-000015.md) | [2,746](/filings/0001386278-25-000034.md) | [3,155](/filings/0001386278-25-000064.md) | [2,570](/filings/0001386278-25-000076.md) | [2,640](/filings/0001386278-26-000045.md) | [2,830](/filings/0001386278-26-000035.md) | [2,317](/filings/0001386278-26-000045.md) |
| Total assets | $m | [4,664](/filings/0001386278-23-000062.md) | [4,817](/filings/0001386278-25-000009.md) | [5,321](/filings/0001386278-24-000031.md) | [5,517](/filings/0001386278-24-000051.md) | [5,285](/filings/0001386278-24-000080.md) | [5,434](/filings/0001386278-26-000015.md) | [5,728](/filings/0001386278-25-000034.md) | [5,583](/filings/0001386278-25-000064.md) | [5,767](/filings/0001386278-25-000076.md) | [5,985](/filings/0001386278-26-000045.md) | [6,651](/filings/0001386278-26-000035.md) | [6,192](/filings/0001386278-26-000045.md) |
| Current liabilities | $m | [3,816](/filings/0001386278-23-000062.md) | [3,953](/filings/0001386278-25-000009.md) | [4,447](/filings/0001386278-24-000031.md) | [4,644](/filings/0001386278-24-000051.md) | [4,306](/filings/0001386278-24-000080.md) | [4,502](/filings/0001386278-26-000015.md) | [4,708](/filings/0001386278-25-000034.md) | [4,591](/filings/0001386278-25-000064.md) | [4,788](/filings/0001386278-25-000076.md) | [5,030](/filings/0001386278-26-000045.md) | [5,645](/filings/0001386278-26-000035.md) | [5,187](/filings/0001386278-26-000045.md) |
| Total liabilities | $m | [3,868](/filings/0001386278-23-000062.md) | [3,958](/filings/0001386278-25-000009.md) | [4,450](/filings/0001386278-24-000031.md) | [4,647](/filings/0001386278-24-000051.md) | [4,353](/filings/0001386278-24-000080.md) | [4,561](/filings/0001386278-26-000015.md) | [4,780](/filings/0001386278-25-000034.md) | [4,663](/filings/0001386278-25-000064.md) | [4,854](/filings/0001386278-25-000076.md) | [5,095](/filings/0001386278-26-000045.md) | [5,710](/filings/0001386278-26-000035.md) | [5,253](/filings/0001386278-26-000045.md) |
| Shareholders' equity | $m | [795](/filings/0001386278-24-000080.md) | [859](/filings/0001386278-26-000015.md) | [871](/filings/0001386278-25-000064.md) | [870](/filings/0001386278-25-000076.md) | [932](/filings/0001386278-25-000076.md) | [874](/filings/0001386278-26-000045.md) | [948](/filings/0001386278-26-000045.md) | [921](/filings/0001386278-26-000045.md) | [913](/filings/0001386278-25-000076.md) | [890](/filings/0001386278-26-000045.md) | [941](/filings/0001386278-26-000045.md) | [939](/filings/0001386278-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.7 d](/filings/0001386278-24-000080.md) | [(34.9) d](/filings/0001386278-26-000015.md) | [89.2](/filings/0001386278-25-000034.md) | [31.5 d](/filings/0001386278-25-000064.md) | [(16.3) d](/filings/0001386278-25-000076.md) | [(23.0) d](/filings/0001386278-26-000015.md) | [109](/filings/0001386278-26-000035.md) | [69.0 d](/filings/0001386278-26-000045.md) | [23.3 d](/filings/0001386278-25-000076.md) | [(62.5) d](/filings/0001386278-26-000015.md) | [95.1](/filings/0001386278-26-000035.md) | [99.6 d](/filings/0001386278-26-000045.md) |
| Capital expenditure | $m | [17.4 d](/filings/0001386278-24-000080.md) | [20.4 d](/filings/0001386278-26-000015.md) | [14.5](/filings/0001386278-25-000034.md) | [17.0 d](/filings/0001386278-25-000064.md) | [20.7 d](/filings/0001386278-25-000076.md) | [22.1 d](/filings/0001386278-26-000015.md) | [19.4](/filings/0001386278-26-000035.md) | [19.5 d](/filings/0001386278-26-000045.md) | [19.8 d](/filings/0001386278-25-000076.md) | [13.8 d](/filings/0001386278-26-000015.md) | [19.0](/filings/0001386278-26-000035.md) | [19.8 d](/filings/0001386278-26-000045.md) |
| Share repurchases | $m | [0.0 d](/filings/0001386278-23-000062.md) | [0.0 d](/filings/0001386278-25-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [53.4](/filings/0001386278-23-000062.md) | [52.0](/filings/0001386278-24-000031.md) | [52.4](/filings/0001386278-24-000051.md) | [52.4](/filings/0001386278-24-000080.md) | [53.3](/filings/0001386278-25-000034.md) | [53.5](/filings/0001386278-25-000064.md) | [53.7](/filings/0001386278-25-000076.md) | [55.3](/filings/0001386278-26-000035.md) | [55.1](/filings/0001386278-26-000045.md) | [55.4](/filings/0001386278-25-000076.md) | [58.0](/filings/0001386278-26-000035.md) | [56.8](/filings/0001386278-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,985,179 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001386278-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.